Clinical Trials Browser

Phase EARLY_PHASE1 × Lung Neoplasms × CNS × Clear all

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT04752267 2024-05-24

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Phase EARLY_PHASE1 Completed

10 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioma, Lung Neoplasms, Melanoma

NCT04864821 2021-05-06

Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor

Phase EARLY_PHASE1 Unknown

24 enrolled

CNSGastrointestinalSarcomaThoracic

Lung Neoplasms, Neuroblastoma, Osteosarcoma, Stomach Neoplasms

NCT00253461 2012-03-20

11C Topotecan PET Imaging

Phase EARLY_PHASE1 Terminated

7 enrolled

CNSGynecologicThoracic

Carcinoma, Ovarian Epithelial, Brain Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT00743353 2009-02-02

K5

Phase EARLY_PHASE1 Completed

16 enrolled

BreastCNSDermatologicHead & NeckSarcomaThoracic

Astrocytoma, Breast Neoplasms, Glioblastoma, Laryngeal Diseases, Lung Neoplasms, Melanoma, Oligodendroglioma, Sarcoma

Clinical Trials

VARTUTRACE

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor

11C Topotecan PET Imaging

K5